[Prospective randomized trial comparing Discovisc versus Healon in phacoemulsification]
- PMID: 17717768
- DOI: 10.4321/s0365-66912007000800007
[Prospective randomized trial comparing Discovisc versus Healon in phacoemulsification]
Abstract
Objective: To compare the intraoperative behaviour of both, DisCoVisc and Healon used as viscoelastics in cataract surgery.
Method: We prospectively evaluated 35 patients with cataracts who underwent phacoemulsification and intraocular lens implantation. Patients were randomized into two groups. Group A included 17 patients in where Healon was used as a viscoelastic, whereas group B included 18 patients in where the viscoelastic used was DisCoVisc. After each procedure, the surgeon filled in a questionnaire describing the behaviour of the viscoelastic during the different stages of phacoemulsification.
Results: DisCoVisc behaved as both cohesive and dispersive viscoelastic during capsulorrhexis, phacoemulsification and viscoelastic aspiration, whereas Healon acted as a cohesive substance during all surgical stages. DisCoVisc enabled better visualization and transparency during all the surgical stages and maintains the capsular bag better during the intraocular lens implantation. Viscoelastic aspiration was easier with Healon.
Conclusions: DisCoVisc is a new viscosurgical device with both cohesive and dispersive properties, which avoids using two different viscoelastics to improve the performance at different surgical stages. DisCoVisc has been shown to be more transparent and provides better anterior chamber maintenance when compared with Healon. Healon was more easily aspirated due to its cohesive character.
Similar articles
-
Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery.Clin Ophthalmol. 2011;5:1381-9. doi: 10.2147/OPTH.S22243. Epub 2011 Sep 23. Clin Ophthalmol. 2011. PMID: 22034557 Free PMC article.
-
Comparison of the clinical performance of Healon 5 and Healon in phacoemulsification.Eur J Ophthalmol. 2002 May-Jun;12(3):205-11. doi: 10.1177/112067210201200306. Eur J Ophthalmol. 2002. PMID: 12113566 Clinical Trial.
-
Prospective randomized comparison of DisCoVisc and Healon5 in phacoemulsification and intraocular lens implantation.Eye (Lond). 2010 Aug;24(8):1376-81. doi: 10.1038/eye.2010.47. Epub 2010 Apr 16. Eye (Lond). 2010. PMID: 20395973 Clinical Trial.
-
Physical Characteristics, Clinical Application, and Side Effects of Viscoelastics in Ophthalmology.J Curr Ophthalmol. 2024 Aug 10;35(4):313-319. doi: 10.4103/joco.joco_178_23. eCollection 2023 Oct-Dec. J Curr Ophthalmol. 2024. PMID: 39281404 Free PMC article. Review.
-
Ophthalmic viscosurgical devices.Curr Opin Ophthalmol. 2008 Jan;19(1):50-4. doi: 10.1097/ICU.0b013e3282f14db0. Curr Opin Ophthalmol. 2008. PMID: 18090898 Review.
Cited by
-
Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery.Clin Ophthalmol. 2011;5:1381-9. doi: 10.2147/OPTH.S22243. Epub 2011 Sep 23. Clin Ophthalmol. 2011. PMID: 22034557 Free PMC article.
-
A clinical comparison between DisCoVisc and 2% hydroxypropylmethylcellulose in phacoemulsification: a fellow eye study.Clinics (Sao Paulo). 2012 Sep;67(9):1059-62. doi: 10.6061/clinics/2012(09)13. Clinics (Sao Paulo). 2012. PMID: 23018304 Free PMC article. Clinical Trial.